A gender lens is needed in hepatitis C elimination research

S. LARNEY ; A. MADDEN ; A. D. MARSHALL ; N. K. MARTIN ; C. TRELOAR | 2022
Dans International Journal of Drug Policy (Vol.103, May 2022) Article : Périodique

The World Health Organisation has established a goal of eliminating the hepatitis C virus (HCV) as a public health threat by 2030. Considerable effort is being directed towards research to support and enhance HCV treatment uptake among people wh[...]

Plus d'info

Ajouter à la sélection

Lien externe

Making legitimacy: Drug user representation in United Nations drug policy settings

A. MADDEN ; K. LANCASTER ; A. RITTER ; C. TRELOAR | 2021
Dans International Journal of Drug Policy (Vol.87, January 2021) Article : Périodique

Background: The importance of engaging people who use drugs in drug policy development is increasingly acknowledged including in recent UN documents. Little scholarly attention has been paid to 'drug user representation' in the global drug polic[...]

Plus d'info

Ajouter à la sélection

Risk for hepatitis C: transition and initiation to injecting drug use among youth in a range of injecting drug user networks

C. TRELOAR ; J. ABELSON ; J. CRAWFORD ; KIPPAX S. ; J. HOWARD ; I. VAN BEEK ; J. COPELAND ; WEATHERALL A. M. ; A. MADDEN | 2003
Rapport

This project, funded by NHMRC and NSW Health, aimed to investigate and report on a number of aspects of initiation and transition to injecting drug use among young people. The report focuses on issues of: - transition to injecting what drugs we[...]

Plus d'info

Ajouter à la sélection